ADIPOQ and Hypertension: Ultimately, in cases of obesity-related hypertension, compensatory mechanisms, adiponectin resistance, and reduced adiponectin clearance—stemming from impaired kidney and liver function—occur together, leading to what is known as the “adiponectin paradox” [53].